Current Clinical and Pharmaceutical Applications of Microarrays: From Disease Biomarkers Discovery to Automated Diagnostics

JALA - Journal of the Association for Laboratory Automation

Volumn 15, Issue 5, 2010, Pages 405-413

  Lagraulet, Adriana ^a  

^a Parc d'Activités Activestre ^*  (France)

Author keywords

Clinical diagnostics; DNA microarrays; Genomics; Protein microarrays

Indexed keywords

APPLICATION LEVEL; ASSOCIATED SOFTWARES; AUTOMATED DIAGNOSTICS; CHROMOSOMAL ABERRATION; CLINICAL DIAGNOSTICS; DATA INTERPRETATION; DISEASE BIOMARKER; DNA MICROARRAYS; FEATURE DETECTION; GENE EXPRESSION PATTERNS; GENOMIC DNA; GENOMICS; HIGH RESOLUTION; HIGH-DENSITY; HIGH-THROUGHPUT SCREENING; PHARMACEUTICAL APPLICATIONS; PROTEIN MICROARRAYS; PROTEIN MOLECULES; TRANSCRIPTOMES;

BIOCHIPS; CHEMICAL DETECTION; DIAGNOSIS; DNA; GENE EXPRESSION;

BIOASSAY;

POLYDEOXYRIBONUCLEOTIDE; TRANSCRIPTOME;

ARTICLE; AUTOMATION; BACTERIAL ARTIFICIAL CHROMOSOME; CHROMOSOME ABERRATION; COMPARATIVE GENOMIC HYBRIDIZATION; COPY NUMBER VARIATION; DNA HYBRIDIZATION; DNA MICROARRAY; ENZYME ACTIVITY; GENE AMPLIFICATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GENOME; GENOME ANALYSIS; GENOTYPE; MICROARRAY ANALYSIS; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 77956820862     PISSN: 15355535     EISSN: 15402452     Source Type: Journal    
DOI: 10.1016/j.jala.2010.06.011     Document Type: Article

References (68)

1. Delpech M. DNA chips. Ann. Biol. Clin. (Paris) 2000, 58:29-38.
2. Hartman M., Loy E.Y., Ku C.S., Chia K.S. Molecular epidemiology and its current clinical use in cancer management. Lancet Oncol. 2010, 11(4):383-390.
3. de Smith A.J., Purmann C., Walters R.G., Ellis R.J., Holder S.E., Van Haelst M.M., Brady A.F., Fairbrother U.L., Dattani M., Keogh J.M., Henning E., Yeo G.S., O'Rahilly S., Froguel P., Farooqi I.S., Blakemore A.I. A deletion of the HBII-85 class of small nucleolar RNAs (snoRNAs) is associated with hyperphagia, obesity and hypogonadism. Hum. Mol. Genet. 2009, 18(17):3257-3265.
4. Karsten S.L., Geshwind D.H. Gene expression analysis using cDNA microarrays. Curr. Protoc. Neurosci. 2002, 28. Chapter 4:Unit 4.
5. Van Gelder R.N., von Zastrow M.E., Yool A., Dement W.C., Barchas J.D., Eberwine J.H. Amplified RNA synthesized from limited quantities of heterogeneous cDNA. Proc. Natl. Acad. Sci. U S A 1990, 87(5):1663-1667.
6. Diboun I., Wernisch L., Orengo C.A., Koltzenburg M. Microarray analysis after RNA amplification can detect pronounced differences in gene expression using limma. BMC Genomics. 2006, 7:252.
7. Smyth G.K., Speed T. Normalization of cDNA microarray data. Methods 2003, 31:265-273.
8. Fujita A., Sato J.R., Rodrigues L.D.O., Ferreira C.E., Sogoyar M.C. Evaluating different methods of microarray normalization. BMC Bioinformatics 2006, 7:469.
9. Yang Y.H., Buckley M.J., Speed T.P. Analysis of cDNA microarray images. Brief. Bioinform. 2001, 2(4):341-349.
10. Fare T.L., Coffey E.M., Dai H., He Y.D., Kessler D.A., Kilian K.A., Koch J.E., LeProust E., Marton M.J., Meyer M.R., Stoughton R.B., Tokiwa G.Y., Wang Y. Effects of atmospheric ozone on microarray data quality. Anal. Chem. 2003, 75:4672-4675.
11. Branham W.S., Melvin C.D., Han T., Desai V.G., Moland C.L., Scully A.T., Fuscoe J.C. Elimination of laboratory ozone leads to a dramatic improvement in the reproducibility of microarray gene expression measurements. BMC Biotechnol. 2007, 7:8.
12. Hu J., He X. Enhanced quantile normalization of microarray data to reduce loss of information in gene expression profiles. Biometrics 2007, 63(1):50-59.
13. Nowak N.J., Miecznikowski J., Moore S.R., Gaile D., Bobadilla D., Smith D.D., Kernstine K., Forman S.J., Mhawech-Fauceglia P., Reid M., Stoler D., Loree T., Rigual N., Sullivan M., Weiss L.M., Hicks D., L Sm Challenges in array comparative genomic hybridization for the analysis of cancer samples. Genet. Med. 2007, 9:585-595.
14. Chen W., Erdogan F., Ropers H.H., Lenzner S,, Ullmann R. CGHPRO-a comprehensive data analysis tool for array CGH. BMC Bioinformatics 2005, 6:85.
15. Lin S., Du P., Jafari N., Ouchi T. Using free and open-source bioconductor packages to analyze array comparative genomics hybridization (aCGH) data. Curr. Genomics 2009, 10:60-63.
16. Pérez-Enciso M., Tenenhaus M. Prediction of clinical outcome with microarray data: a partial least squares discriminant analysis (PLS-DA) approach. Hum. Genet. 2003, 112:581-592.
17. Tusher V.G., Tibshiranl R., Chu G. Significance analysis of microarrays applied to the ionizing radiation response. PNAS 2001, 98:5116-5121.
18. Pinkel D., Segraves R., Sudar D., Clark S., Poole I., Zhai Y., Dairkee S.H., Ljung B.-M., Gray J.W., Albertson D.G. High resolution analysis of DNA copy number variations using comparative genomic hybridization to microarrays. Nat. Genet. 1998, 20:207-211.
19. Malan V., Raoul O., Firth H.V., Royer G., Turleau C., Bernheim A., Willatt L., Munnich A., Vekemans M., Lyonnet S., Cormier-Daire V., Colleaux L. 19q13.11 deletion syndrome: a novel clinically recognisable genetic condition identified by array comparative genomic hybridisation. J. Med. Genet. 2009, 46(9):635-640.
20. Redon R., Ishikawa S., Fitch K.R., Feuk L., Perry G.H., Andrews D.T., Fiegler H., Shapero M.H., Carson A.R., Chen W., Cho E.K., Dallaire S., Freeman J.L., Gonzalez J.R., Gratacos M., Huang J., Kalaitzopoulos D., Komura D., MacDonald J.R., Marxhall C.R., Mei R., Mongomery L., Nishimura K., Okamura K., Shen F., Somerville M.J., Tchinda J., Valsesia A., Woodwark C., Yang F., Whang J., Zerjal T., Zhang J., Armengol L., Conrad D.F., Estivill X., Tyler-Smith C., Carter N.P., Aburatani H., Lee C., Jones K.W., Scherer S.W., Hurles M.E. Global variation in copy number in the human genome. Nature 2006, 444:444-454.
21. Gunn S.R., Hohammed M.S., Gorre M.E., Cotter P.D., Kim J., Bahler D.W., Preobrazhensky S.N., Higgins R.A., Bolla A.R., Ismail S.H., de Jong D., Eldering E., van Oers M.H.J., Clemens M.H.M., Keating M.J., Schlette E.J., Abruzzo L.V., Robetorye R.S. Whole-genome scanning by array comparative genomic hybridization as a clinical tool for risk assessment in chronic lymphocytic leukemia. J. Mol. Diagn. 2008, 10:442-451.
22. Roos L., Jonch A.E., Kjaergaard S., Taudorf K., Simonsen H., Hamborg-Petersen B., Brondum-Nielsen K., Kirchhoff M. A new microduplication syndrome encompassing the region of the Miller-Dieker (17p13 deletion) syndrome. J. Med. Genet. 2009, 46(10):703-710.
23. Tan N.H., Palmer R., Wang R. Evaluation of the efficacy of constitutional array-based comparative genomic hybridization in the diagnosis of aneuploidy using genomic and amplified DNA. J. Obstet. Gynaecol. Res. 2010, 36:19-26.
24. Menten B., Maas N., Thienpont B., Buysse K., Vandesompele J., Melotte C., de Ravel T., {Van Vooren} S., Marinen P., Fryns J.-P., Mortier G., Devriendt K., Speleman F., Vermeesch J.R. Emerging patterns of cryptic chromosomal imbalance in patients with idiopathic mental retardation and multiple congenital anomalies: a new series of 140 patients and review of published reports. J. Med. Genet. 2006, 43:625-633.
25. Veltman J.A., Vries B.B.A. Diagnostics genome profiling: unbiased whole genome or targeted analysis. J. Mol. Diagn. 2006, 8:534-539.
26. Shinawi M., Erez A., Shardy D.L., Lee B., Naeem R., Weissenberger G., Chinault A.C., Cheung S.W., Plon S.E. Syndromic thrombocytopenia and predisposition to acute myelogenous leukemia caused by constitutional microdeletions on chromosome 21q. Blood 2008, 112(4):1042-1047.
27. Thuresson A.C., Bondeson M.L., Edeby C., Ellis P., Langford C., Dumanski J.P., Annerén G. Whole-genome array-CGH for detection of submicroscopic chromosomal imbalances in children with mental retardation. Cytogenet. Genome Res. 2007, 118:1-7.
28. Li M.M., Nimmakayalu M.A., Mercer D., Andersson H.C., Emanuel B.S. Characterization of a cryptic 3.3 Mb deletion in a patient with a " balanced t(15;22) translocation" using high density oligo array CGH and gene expression arrays. Am. J. Med. Genet. A. 2008, 146:368-375.
29. Fiegler H., Gribble S.M., Burford D.C., Carr P., Prigmore E., Porter K.M., Clegg S., Crolla J.A., Dennis N.R., Jacobs P., Carter N.P. Array painting: a method for the rapid analysis of aberrant chromosomes using DNA microarrays. J. Med. Genet. 2003, 40(9):664-670.
30. Gribble S.M., Ng B.L., Prigmore E., Fitzgerald T., Carter N.P. Array painting: a protocol for the rapid analysis of aberrant chromosomes using DNA microarrays. Nat. Protoc. 2009, 4:1722-1736.
31. Bailey K.R., Cheng C. Conference Scene: the great debate: genome-wide association studies in pharmacogenetics research, good or bad?. Pharmacogenomics 2010, 11(3):305-308.
32. Alonso R., Defesche J.C., Tejedor D., Castillo S., Stef M., Mata N., Gomez-Enterria P., Martinez-Faedo C., Forga L., Mata P. Genetic diagnosis of familial hypercholesterolemia using a DNA-array based platform. Clin. Biochem. 2009, 42:899-903.
33. Schena M., Shalon D., Davis R.W., Brown P.O. Quantitative monitoring of gene expression patterns with a compementary DNA microarray. Science 1995, 270:467-470.
34. Consortium IHGS Finishing the euchromatic sequence of the human genome. Nature 2004, 431:931-945.
35. Little P.F.R. Structure and funciton of the human genome. Genome Res. 2005, 15:1759-1766.
36. Kloosterman W.P., Plasterk R.H.A. The diverse functions of microRNAs in animal development and disease. Dev. Cell. 2006, 11:441-450.
37. Davis B.N., Hata A. Regulation of microRNA Biogenesis: a miRiad of mechanisms. Cell Commun. Signal. 2009, 7:1-22.
38. Bushati N., Cohen S.M. microRNA functions. Annu. Rev. Cell Dev. Biol. 2007, 23:175-205.
39. Shingara J., Keiger K., Shelton J., Laosinchai-Wolf W., Powers P., Conrad R., Brown D., Labourier E. An optimized isolation and labeling platform for accurate microRNA expression profiling. RNA 2005, 11:1461-1470.
40. Wang H., Ach R.A., Curry B. Direct and sensitive miRNA profiling from low-input total RNA. RNA 2007, 13(1):151-159.
41. Bloomston M., Frankel W.L., Petrocca F., Volinia S., Alder H., Hagan J.P., Liu C.-G., Bhatt D., Taccioli C., Croce C.M. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 2007, 297:1901-1908.
42. Calin G.A., Ferracin M., Cimmino A., {Di Leva} G., Shimizu M., Wojcik S.E., Iorio M.V., Visone R., Sever N.I., Fabbri M., Luliano R., Palumbro T., Pichiorri F., Roldo C., Garzon R., Sevigniani C., Rassenti L., Alder H., Volinia S., Liu C.G., Kipps T.J., Negrini M., Croce C.M. A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N. Engl. J. Med. 2005, 353:1793-1801.
43. Shetter A.J., Leung S.Y., Sohn J.J., Zanetti K.A., Bowman E.D., Yanaihara N., Yuen S.T., Chan T.L., Kwong D.L., Au G.K., Liu C.G., Calin G.A., Croce C.M., Haris C.C. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 2008, 299:425-436.
44. Harris C., Ghaffari N. Biomarker discovery across annotated and unannotated microarray datasets using semi-supervised learning. BMC Genomics 2008, 9:S7.
45. Nguyen D.V. Partial least squares dimension reduction for microarray gene expression data with a censored response. Math. Biosci. 2005, 193:119-137.
46. Zhan F.H., Barlogie B., Shaughnessy J.D.J. Gene expression profiling defines a high-risk entity of multiple myelome. J. Cent S Univ. (Med. Sci.). 2007, 32:191-203.
47. Lee J.-S., Chu I.-S., Heo J., Calvisi D.F., Sun Z., Roskams T., Durnez A., Demetris A.J., Thorgeirsson S.S. Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling. Hepatology 2004, 40:667-676.
48. Roepman P., Schuurman A., Delahaye L.J.M.J., Witteveen A.T., Floore A.N., Glas A.M. A gene expression profile for detection of sufficient tumor cells in breast tumor tissue: microarray diagnosis eligibility. BMC Med. Genomics 2009, 2:52.
49. Mutch D.M., Temani M.R., Henegar C., Combes F., Pelloux V., Holst C., Sorensen T.L.A., Astrup A., Martinez J.A., Saris W.H.M., Viguerie N., Langin D., Zucker J.-D., Clément K. Adipose gene expression prior to weight loss can differentiate and weekly predict dietary responders. PLoS ONE 2007, 2:e1344.
50. Nilsen T.W., Gravely B.R. Expansion of the eukaryotic proteome by alternative splicing. Nature 2010, 463:457-463.
51. Mirza S.P., Olivier M. Methods and approaches for the comprehensive characterization and quantification of cellular proteomes using mass spectrometry. Physiol. Genomics 2008, 33:3-11.
52. Lopez J.L. Two-dimensional electrophoresis in proteome expression analysis. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2007, 849:190-202.
53. Spisák S., Guttman A. Biomedical applications of protein microarrays. Curr. Med. Chem. 2009, 16:2806-2815.
54. Stoevesandt O. Protein microarrays: high-throughput tools for proteomics. Expert Rev. Proteomics 2009, 6:145-157.
55. Matsubara J., Ono M., Honda K., Negishi A., Ueno H., Okusaka T., Furuse J., Furuta K., Sugiyama E., Saito Y., Kaniwa N., Sawada J., Shoji A., Sakuma T., Chiba T., Saijo N., Hirohashi S., Yamada T. Survival prediction for pancreatic cancer patients receiving gemcitabine treatment. Mol. Cell. Proteomics 2010, 9:695-704.
56. Tsolakos N., Techanukul T., Wallington A., Zhao Y., Jones C., Nagi J., Wheeler J.X. Comparison of two combinations of cyanine dyes for prelabelling and gel electrophoresis. Proteomics 2009, 9:1727-1730.
57. Ernst L.A., Gupta R.K., Mujumdar R.B., Waggoner A.S. Cyanine dye labeling reagents for sulfhydryl groups. Cytometry 1989, 10:3-10.
58. Miller J.C., Zhou H., Kwekel J., Cavallo R., Burke J., Butler E.B., Teh B.S., Haab B.B. Antibody microarray profiling of human prostate cancer sera: antibody screening and identification of potential biomarkers. Proteomics 2003, 3:56-63.
59. Bacarese-Hamilton T., Ardizzoni A., Gray J., Crisanti A. Protein arrays for serodiagnosis of disease. Methods Mol. Biol. 2004, 264:271-283.
60. Bacarese-Hamilton T., Mezzasoma L., Ingham C., Ardizzoni A., Rossi R., Bistoni F., Crisanti A. Detection of allergen-specific IgE on microarrays by use of signal amplification techniques. Clin. Chem. 2002, 48:1367-1370.
61. Varnum S.M., Woodbury R.L., Zangar R.C. A protein microarray ELISA for screening biological fluids. Methods Mol. Biol. 2004, 264:161-172.
62. Nishizuka S., Charboneau L., Young L., Major S., Reinhold W.C., Waltham M., Kouros-Mehr H., Bussey K.J., Lee J.K., Espina V., Munson P.J., Iii E.P., Liotta L.A., Weinstein J.N. Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays. Proc. Natl. Acad. Sci. U S A 2003, 100:14229-14234.
63. Ma Y., Ding Z., Qian Y., Shi X., Castranova V., Harner E.J., Guo L. Predicting cancer drug response by proteomic profiling. Clin. Cancer Res. 2006, 12:4583-4589.
64. Voshol H., Ehrat M., Traenkle J., Bertrand E., van Oostrum J. Antibody-based proteomics: analysis of signaling networks using reverse protein arrays. FEBS J. 2009, 276:6871-6879.
65. Schröder C., Jacob A., Tonack S., Radon T.P., Sill M., Zucknick M., Rüffer S., Costello E., Neoptolemos J.P., Crnogorac-Jurcevic T., Bauer A., Fellenberg K., Hoheisel J.D. Dual-color proteomic profiling of complex samples with a microarray of 810 cancer-related antibodies. Mol. Cell. Proteomics 2010, 9:1271-1280.
66. Li T., Liu D., Wang Z. Screening kinase inhibitors with a microarray-based fluorescent and resonance light scattering assay. Anal. Chem. 2010, 82:3067-3072.
67. Kadanga A.K., Leroux C., Bonnet M., Chauvet S., Cassar-Malek I., Hocquette J.-F. Image analysis and data normalization procedures are crucial for microarray analyses. Gene Regul. Syst. Biol. 2008, 2:107-112.
68. Brazma A., Hingamp P., Quackenbush J., Sherlock G., Spellman P., Stoeckert C., Aach J., Ansorge W., Bal C.A., Causton H.C., Gaasterland T., Clenisson P., Holstege F.C.P., Kim I.F., Markowitz V., Matese J.C., Parkinson H., Robinson A., Schulze Kremer S., Stewart J., Taylor R., Vilo J., Vingron M. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat. Genet. 2001, 29:365-374.